Amicus Therapeutics, Inc. Logo Image

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. Banner Image

Most Recent Annual Report

2017 Annual Report and Form 10K

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. has reached its limit for free report views.

Amicus Therapeutics, Inc. does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Amicus Therapeutics, Inc.

201-500 Employees
Based in Cranbury, New Jersey

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol